KOSPICosmetics123690

Hankook Cosmetics

₩4,950▲ 1.23%2026-11-18 close
Market Cap
₩79.5B
Turnover
₩200M
Volume
50K
Shares out.
16.1M
PER
82.8×
PBR
2.2×
EPS
₩59
Dividend Yield
0.00%

PER, EPS, PBR and BPS are calculated in-house from the last 4 quarters (2025Q4–2026Q3) · Dividend yield is based on ₩0 per share · Prices as of the 2026-11-18 close

01

Report overview

Quarterly Profit Rebound Tests the Earnings Base

Hankook Cosmetics' operating profit fell to KRW 528 million in 2025 before returning to a KRW 1.21 billion profit in Q3 2026, but large swings between quarters mean the recovery still needs to be confirmed over more quarters.

  1. 1

    Disclosed 2025 results show revenue of KRW 85 billion (down 8.4% year on year) and operating profit of KRW 528 million (down 85.8%), a step back from 2024.

  2. 2

    Operating profit in Q3 2026 was KRW 1.21 billion, up 93.6% from the year-earlier quarter, following an operating loss of KRW 316 million in Q2 2026.

  3. 3

    Controlling shareholders' net profit totaled KRW 957 million over the last four quarters (Q4 2025 to Q3 2026), with quarterly results alternating between losses and profits.

  4. 4

    The debt ratio stood at 67.6% at end-2025, down from 95.9% in 2022, with total liabilities of KRW 22.7 billion and total equity of KRW 33.6 billion.

  5. 5

    Korea's cosmetics exports reached USD 7 billion in H1 2026, up 27.3%, while China's share slipped to 14.4%, so the mix of export markets is shifting even as demand grows.

02

Business structure

Hankook Cosmetics is a cosmetics company listed on KOSPI. Annual revenue rose from KRW 66 billion in 2022 to KRW 78.7 billion in 2023 and KRW 92.8 billion in 2024, then declined to KRW 85 billion in 2025; the largest year in the 2022 to 2025 span was 2024 and the smallest was 2022.

The industry value chain is split among brand owners, ODM and packaging manufacturers that produce products on commission, and distributors that handle overseas channels.

Leading domestic ODM players Cosmax and Kolmar Korea both passed KRW 2 trillion in annual revenue in 2025, and Kolmar Korea became the first in the industry to be listed as a large business group, according to press coverage.

Hankook Cosmetics' 2025 revenue of KRW 85 billion is small by comparison with these leading ODM companies. Korea exported cosmetics to 202 countries in 2025, and in H1 2026 the United States accounted for 20.7% of exports, overtaking China at 14.4%.

Across the industry, H1 2026 exports of USD 7 billion set a half-year record, extending the growth trend. Hankook Cosmetics' operating margin was 0.6% in 2025, so the profit retained from each unit of sales is thin.

Q3 2026 revenue was KRW 20.4 billion, down 4.3% from the year-earlier quarter, leaving quarterly sales in the low KRW 200 billion range.

03

Earnings trend

Quarterly revenue · Operating profit
RevenueOperating profit
Annual revenue · Operating profit
RevenueOperating profit
Quarterly results · Last 5 quarters
QuarterRevenueOperating profitOp. margin
2025Q3₩21.3B₩600M2.9%
2025Q4₩18.6B-₩1.6B−8.8%
2026Q1₩20.9B₩1.9B9.2%
2026Q2₩21B-₩300M−1.5%
2026Q3₩20.4B₩1.2B5.9%
Annual results
YearRevenueOperating profitNet income (parent)Op. marginROEDebt-to-equity
2022₩66B-₩23,014,169₩600M0.0%2.6%95.9%
2023₩78.7B₩3.1B₩3.5B3.9%13.7%91.6%
2024₩92.8B₩3.7B₩4.6B4.0%15.2%90.7%
2025₩85B₩500M₩1.1B0.6%3.4%67.6%

Consolidated basis (financial statements including subsidiaries) · Final figures from DART filings · Net income attributable to owners of the parent · Data as of 2026-11-17

04

Earnings analysis

Annual revenue rose from KRW 66 billion in 2022 to KRW 78.7 billion in 2023 (up 19.2% year on year) and KRW 92.8 billion in 2024 (up 17.9%), then fell to KRW 85 billion in 2025 (down 8.4%). The largest year in the 2022 to 2025 span was 2024, and the smallest was 2022.

Operating profit moved from an operating loss of KRW 23.01 million in 2022 to KRW 3.05 billion in 2023, a swing to profit, then rose to KRW 3.71 billion in 2024 (up 21.6%) before falling to KRW 528 million in 2025 (down 85.8%).

The operating margin went from -0.0% in 2022 to 3.9% in 2023 and 4.0% in 2024, before dropping to 0.6% in 2025. In 2022, despite an operating loss, controlling shareholders' net profit was KRW 597 million because the income tax line supported profit.

It then rose to KRW 3.51 billion in 2023 (up 487.5%) and KRW 4.59 billion in 2024 (up 30.8%), before falling to KRW 1.13 billion in 2025 (down 75.5%). In the same year, net profit including non-controlling interests was KRW 1.15 billion, a different figure from controlling shareholders' net profit.

The debt ratio fell from 95.9% in 2022 to 67.6% in 2025, and at end-2025 total equity was KRW 33.6 billion, all attributable to controlling shareholders, against total liabilities of KRW 22.7 billion.

Operating cash flow was KRW 3.06 billion in 2022, KRW 4.86 billion in 2023, KRW 3.14 billion in 2024 and KRW 2.91 billion in 2025, staying near KRW 3 billion in 2025 even as profit fell.

On a quarterly basis, Q3 2025 revenue of KRW 21.3 billion and operating profit of KRW 623 million were followed by Q4 2025 revenue of KRW 18.6 billion (down 12.7% quarter on quarter) and an operating loss of KRW 1.64 billion, a swing to loss.

Q1 2026 revenue was KRW 20.9 billion (up 12.7% quarter on quarter) with operating profit of KRW 1.92 billion, a return to profit. Q2 2026 revenue of KRW 21 billion (up 0.5%) came with an operating loss of KRW 316 million, a return to loss.

Q3 2026 revenue was KRW 20.4 billion (down 3.2% quarter on quarter and down 4.3% year on year), with operating profit of KRW 1.21 billion (up 93.6% year on year).

Controlling shareholders' net profit was KRW 969 million in Q3 2026 (up 8.5% year on year), but the last four quarters totaled KRW 957 million; the reason operating profit rose while revenue fell needs confirmation from the cost items in the quarterly report.

05

Industry analysis

According to preliminary data from the Ministry of Food and Drug Safety, cosmetics exports reached USD 7 billion in H1 2026, up 27.3% from the same period a year earlier and a record for a half-year period. By region, the United States accounted for 20.7% of H1 exports (USD 1.45 billion), ahead of China at 14.4%.

Brokerage forecasts differ: NH Investment & Securities projected 2026 total export growth of 21.0% and a 6.0% decline for China and Hong Kong, while Hana Securities put 2026 export growth at 33%. ODM results show growth alongside differing profit outcomes.

In Q3 2026, according to press coverage, Cosmax's operating profit surged 95%, Kolmar Korea's rose 40.5%, and Cosmecca Korea's grew only 0.1%. Hana Securities expected combined revenue of five major ODM and packaging companies to rise 39% year on year.

In Europe, Korean products held a 5.9% share of EU cosmetics imports in the year-to-date through Q2 2026, compared with 23.2% for French products, a share that remains low. Whether competitiveness in price and formulation can absorb tariff increases is cited as the key test for industry results in the second half.

Hankook Cosmetics' 2025 revenue of KRW 85 billion is far smaller than that of the leading ODM companies, so the benefits of industry growth appear more concentrated among the larger players.

06

Outlook

In its H2 2026 outlook, NH Investment & Securities identified the performance of Western markets as the key driver for the second half, and expected revenue in Europe to grow alongside direct market entry and the use of vendors.

The same report described US demand, with K-beauty brands supplying initial stock to offline chains including Ulta Beauty, Sephora, Target, Costco and Walmart from 2025 and now entering a phase of expanding reorders.

Among domestic ODM companies, Cosmax, Kolmar Korea and Cosmecca Korea raised standalone revenue growth guidance after their Q1 2026 results, citing better-than-expected order books.

Hankook Cosmetics' quarterly revenue has moved in the low KRW 200 billion range, at KRW 20.9 billion in Q1 2026, KRW 21 billion in Q2 and KRW 20.4 billion in Q3, so whether industry improvement translates into higher sales remains to be confirmed.

Operating profit returned to the black in Q3 2026, but with an operating loss in Q2 2026 and a loss in Q4 2025 on record, whether quarterly profits build steadily has yet to be established.

The gap between export forecasts is likely to narrow depending on how much US and European demand offsets weaker China demand in the second half.

The Q4 2026 and full-year 2026 results will first be confirmed in the 2026 annual report, so the operating margin and controlling shareholders' net profit in that filing will show how much of the industry upturn is reflected in the company's numbers.

07

Valuation

PER
82.8×
PBR
2.2×
ROE
2.7%
EPS
₩59
BPS
₩2,215
Dividend per share
₩0

The current multiples are highly sensitive to the earnings base. Controlling shareholders' net profit totaled only KRW 957 million over the last four quarters, so the price-to-earnings ratio moves sharply with small changes in quarterly profit.

On FnGuide's data, the annual peak price-to-earnings ratio was 27.8x in 2023, 25.9x in 2024 and 31.3x in 2025, while the annual lows were 12.7x, 14.5x and 14.9x. Over 2022 to 2025, the annual peak price-to-book ratio ranged from 4.4x to 7.8x and the annual low from 2.2x to 4.1x.

The current price-to-book ratio sits near the lower end of the annual low range. Over several years, operating profit moved from an operating loss in 2022 to a 4.0% operating margin in 2024, then fell to 0.6% in 2025.

Among peers, Q3 2026 operating profit rose 95% at Cosmax and 40.5% at Kolmar Korea, showing wide differences in earnings growth across companies in the same industry.

PER, EPS, PBR and BPS are all calculated in-house (the same method as Naver and Toss) · Dividend yield = cash dividend per share from DART filings (supplemented by KRX) ÷ current price · As of 2026-11-17

08

Bull factors

Export tailwind

According to preliminary Ministry of Food and Drug Safety data, cosmetics exports reached USD 7 billion in H1 2026, up 27.3%, a half-year record. NH Investment & Securities put full-year 2026 export growth at 21.0% in its H2 outlook. A supportive industry backdrop gives room for the sales base to recover, which is the main bullish factor.

Quarterly profit returns

Operating profit returned to KRW 1.92 billion in Q1 2026 and reached KRW 1.21 billion in Q3 2026, up 93.6% year on year. The Q3 return to profit followed an operating loss of KRW 316 million in Q2 2026, a sign that quarterly profitability is recovering. The causes still need to be confirmed in the quarterly reports.

Stable operating cash generation

Operating cash flow was positive in every year from 2022 to 2025, ranging from KRW 2.91 billion to KRW 4.86 billion. Even with 2025 operating profit falling to KRW 528 million, operating cash flow was KRW 2.91 billion, showing that cash generation does not move in step with quarterly profit swings. Together with the lower debt ratio, this is a stabilizing factor for the financial base.

09

Bear factors

Sharp profit decline in 2025

Operating profit fell to KRW 528 million in 2025, down 85.8%, and the operating margin dropped to 0.6%. Controlling shareholders' net profit declined 75.5% to KRW 1.13 billion. The thinner profit base compared with 2024 is the main bearish factor.

Repeated quarterly losses

Operating losses occurred in Q4 2025 (KRW 1.64 billion) and Q2 2026 (KRW 316 million), and Q2 2026 also recorded a controlling-shareholder net loss of KRW 532 million. Profitable quarters did occur, but controlling shareholders' net profit over the last four quarters totaled only KRW 957 million. Frequent reversals make quarterly earnings hard to forecast.

Stagnant revenue and a shrinking China share

Q3 2026 revenue was KRW 20.4 billion, down 4.3% from the year-earlier quarter. In H1 2026 China's share of Korean cosmetics exports slipped to 14.4%, behind the US at 20.7%. Company revenue declined even as industry exports grew, so a sales recovery needs to be confirmed in further quarterly data.

10

Risk factors

Tariffs and US market dependence

The US accounted for 20.7% of Korean cosmetics exports in H1 2026, ahead of China at 14.4%. Greater reliance on the US market links tariff policy directly to industry exports and profits. Whether price and formulation competitiveness can absorb tariff increases is flagged as the key second-half test.

Weaker China demand

NH Investment & Securities expects 2026 exports to China and Hong Kong to fall 6.0%. If Chinese demand stays weak, export growth would depend more heavily on the US and Europe, making channel access in those markets decisive for results.

Earnings base and quarterly volatility

The 0.6% operating margin in 2025 shows how quickly profit can turn into a loss when sales soften. Operating losses appeared in Q4 2025 and Q2 2026. Whether earnings strength is restored will be clearer from the full-year operating margin in the 2026 annual report.

11

What to watch next

  1. End of December 2026

    Year-end cosmetics export figures are finalized. This is the point to test whether Hana Securities' view that growth could rise further on Black Friday and Chinese demand holds.

  2. Early January 2027

    The Ministry of Food and Drug Safety is expected to release preliminary full-year 2026 cosmetics export data, following the early-January release for 2025. The result will show whether total growth is closer to NH's 21.0% forecast or Hana's 33% forecast.

  3. March 31, 2027

    This is the filing deadline for the 2026 annual report. Q4 2026 and full-year revenue, operating profit, operating margin (0.6% in 2025) and controlling shareholders' net profit will be confirmed. This is the point to check how the quarterly series reconciles with the annual figures.

  4. Around May 15, 2027

    This falls around the filing deadline for the Q1 2027 quarterly report. It is the point to check whether profitability holds against the KRW 1.92 billion operating profit of Q1 2026, or whether another swing to loss recurs.

12

Overall view

Hankook Cosmetics' disclosed results peaked in 2024, with revenue of KRW 92.8 billion and operating profit of KRW 3.71 billion, before slipping in 2025. Operating profit fell to KRW 528 million and the operating margin to 0.6% in 2025.

Quarterly results in 2026 alternated between profit and loss, and Q3 2026 operating profit reached KRW 1.21 billion, up 93.6% year on year. On the financial side, the debt ratio fell from 95.9% in 2022 to 67.6% in 2025, and operating cash flow was positive every year.

The industry backdrop is supportive, with H1 2026 cosmetics exports of USD 7 billion up 27.3%, but a smaller China share and tariff risks are also cited.

Among leading ODM companies, third-quarter profits rose sharply, yet wide gaps between companies mean the pace at which industry strength reaches each company's earnings differs. Bullish and bearish factors are laid out here at equal weight based on disclosed information.

The next checkpoint is the 2026 annual report, due by March 31, 2027, which will confirm the full-year operating margin and Q4 2026 results.

13

Sources

  1. Korea Exchange (KRX) — Prices · Market Cap · Volume
  2. FSS electronic disclosure system (DART) — Financial statements · Dividend filings
Show 18 more articles and sources
  1. kr.investing.com
  2. m.finance.daum.net
  3. valueline.co.kr
  4. markets.hankyung.com
  5. markets.hankyung.com
  6. google.com
  7. stockeasy.intellio.kr
  8. comp.fnguide.com
  9. magazine.hankyung.com
  10. huffingtonpost.kr
  11. issueinsight.co.kr
  12. finance.thesmileinfo.com
  13. money2.daishin.co.kr
  14. view.asiae.co.kr
  15. feat.page
  16. kcia.or.kr
  17. uppity.co.kr
  18. vegannews.co.kr

Report written 2026-11-18 · Data as of 2026-11-17

This content is AI analysis of market data and web search results, provided for information only. It is not a solicitation or recommendation to invest. Investment decisions and their consequences are the investor's own responsibility. Data may be delayed or contain errors.

Other reports in this industry

View industry analysis